By measuring IGF-1 during treatment, the doctor can tell if the sermorelin dose is sufficient (IGF-1 should rise into a target range) or if adjustments are needed
Investigational interest includes relationships to oxidative metabolism , sirtuin-linked pathways, and age-related bioenergetic decline
Adequate blood glucose monitoring should be continued and followed
Two observational studies reported similar high rates of efficacy, including significant pain relief in 91% of patients after six weeks of treatment accompanied by decreases in frequency and increases in voided volumes 144 and after an average one year of treatment, 87% of patients reporting that they were pain-free with similar improvements in voiding parameters
As discussed in the CY 2021 OPPS/ASC final rule with comment period, we reiterate that the OPPS is a prospective payment system
How might that matter for ulcerative colitis or other colitis states